Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Recruiting
Observational Study
OsteoporosisOsteoarthritis, HipHip FracturesClonal Hematopoiesis of Indeterminate PotentialAging
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
24 (estimated)
Sponsor
Imelda Hospital, Bonheiden · Other
Who this trial is looking for
This trial is looking for older adults, 65 years and above, who are having hip surgery. Participants will provide blood and bone marrow samples for research on certain genetic changes and their effects.
Are You a Good Fit for This Trial?
You may be able to join if
I am 65 years old or older
You may not be able to join if
I have a known blood condition like leukemia or cancer
I am unable to provide written informed consent
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression p…
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age 65 years and older
Exclusion Criteria:
* known haematological condition (myelodysplasia, leukemia, cancer)
* inability to provide written informed consent
Inclusion Criteria:
* Age 65 years and older
Exclusion Criteria:
* known haematological condition (myelodysplasia, leukemia, cancer)
* inability to provide written informed consent
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.